FAERS manufacturer drug profile

OXYCODONE HCL AND ACETAMINOPHEN · NOVARTIS PHARMACEUTICAL

FAERS manufacturer and drug safety profile

Key facts

Drug OXYCODONE HCL AND ACETAMINOPHEN
Manufacturer (report sender) NOVARTIS PHARMACEUTICAL

At a glance

  • 1,000+ FAERS reports from this manufacturer
  • 10–99 Reports with death as outcome
  • 100–999 Reports with hospitalization
  • 1–9 Life-threatening outcomes
  • 1,000+ Distinct reaction terms reported
  • 1,000+ Reactions flagged by Orca1 signal analytics
  • Yes Serious outcome flagged by Orca1 signal analytics
  • Other Serious, Hospitalization, Death, Disability, Life-Threatening Outcome categories reported

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FAERS manufacturer and drug safety profiles

Manufacturer drug profiles aggregate the FAERS reports that one manufacturer sent to the FDA naming the drug as a suspect product, so the same drug can be compared across manufacturers. Reaction terms are counted but not listed here; reports are unverified and do not by themselves establish causation.

Source: U.S. Food and Drug Administration (FDA), FAERS public data; aggregation by Orca1

Browse all FAERS manufacturer and drug safety profiles